Objective
Kidney Disease in England costs more than breast, lung, colon and skin cancer combined. In particular, chronic kidney disease (CDK) affects 10% of the population worldwide. This is bound to increase as our population ages and, if CKD is not detected early enough, the patient may progress to kidney failure which requires therapies (dialysis or transplantation) that are extremely costly and weighs heavily on healthcare budgets. Even though several cheap traditional tests already exist based on a diagnosis of urinal or blood samples, there is no technology available to measure both key RNA biomarkers of kidney diseases and perform traditional chemical analysis. The development of fast multiplex quantitative PCR (qPCR) technologies offers a unique opportunity to propose a Point of Care Test (PoCT) able to perform new multifunctional cheap diagnostics.
By hiring an Innovation Associate with an expertise in microbiology and chemistry, ELVESYS wants to develop the first multifunctional, fast and affordable PoCT device for kidney disease diagnostics. This system will enable any practitioner to propose a diagnosis based on the simultaneous analysis of urinal and blood samples in a single test during the time of a visit to the doctor’s office.
The Innovation Associate will benefit from ELVESYS expertise in the world fastest multiplex qPCR system to develop this first prototype. The MULTIDET project is relevant to bring a PoCT system to the market within the next couple of years. This system will bring ELVESYS to a pioneering position for multifunctional PoCT systems to solve medical and social issues of kidney diseases that weigh severely on the EU healthcare systems. This project will also allow ELVESYS to train an Innovation Associate in entrepreneurship so that they can later become part of the team or start their own spin-off company to commercialize the PoCT system developed.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine oncology skin cancer
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs antibiotics
- medical and health sciences basic medicine pathology
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance antibiotic resistance
- medical and health sciences clinical medicine nephrology kidney diseases
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.2.2. - Enhancing the innovation capacity of SMEs
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
CSA - Coordination and support action
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-INNOSUP-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
75011 PARIS
France
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.